Clinical Trials
36 trialsSAKHI
University of California, Irvine
Contrast PMR
Hyperfine
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
National Institutes of Health Clinical Center (CC)
Rituximab for PTLD Prevention in Solid Organ Transplant Recipients With EBV DNAemia
Columbia University
TAOIST
Hospices Civils de Lyon
Infectious Complications in Hematological Patients Under Treatment With Bispecific Antibodies.
Infanta Leonor University Hospital
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
National Institutes of Health Clinical Center (CC)
SIMA
AstraZeneca
RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study
Pfizer
Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction
University of California, Los Angeles
PRAGMATIC
The University of Queensland
Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
National Institutes of Health Clinical Center (CC)
SHARP
Johns Hopkins Bloomberg School of Public Health
RIFT-HPV
Institut d'Investigació Biomèdica de Bellvitge
PREVENT2
Weill Medical College of Cornell University
Effect of Different HPV Education Methods on Vaccination Intention in Young Women
Kahramanmaras Sutcu Imam University
RIFT-SSA
Institut d'Investigació Biomèdica de Bellvitge
Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
Brigham and Women's Hospital
Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging
National Vaccine and Serum Institute, China
Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells
UNC Lineberger Comprehensive Cancer Center
ProBE-PC
Albany Medical College
Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine
Karolinska Institutet
CIFO
Assistance Publique - Hôpitaux de Paris
PRESAGE
Assistance Publique - Hôpitaux de Paris
WEARABLES
Murdoch Childrens Research Institute
A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL)
Thomas Jefferson University
UNC Pleural Fluid Registry
UNC Lineberger Comprehensive Cancer Center
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)
Monash University
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)
Monash University
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)
Monash University
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)
Monash University
Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract
Centre Antoine Lacassagne
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants
ModernaTX, Inc.
Vaccine Responsiveness After CAR-T Cell Therapy
Fred Hutchinson Cancer Center
Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-associated Diseases.
The Affiliated Hospital of Xuzhou Medical University
Isbaar
University of Minnesota